Clinical Trial Update: Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating continuous Endostar infusion combined with radiotherapy for esophageal cancer; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN